adrenergic beta-2 receptor agonists

Preferred Label : adrenergic beta-2 receptor agonists;

MeSH definition : Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS.;

MeSH synonym : adrenergic beta2-Agonists; adrenergic beta2 agonists; beta2-Agonists, adrenergic; adrenergic beta-2 agonists; adrenergic beta 2 agonists; agonists, adrenergic beta-2; beta-2 agonists, adrenergic; adrenergic beta-2 receptor agonist; adrenergic beta 2 receptor agonist; adrenergic beta 2 receptor agonists;

CISMeF synonym : agonistes des récepteurs béta2 adrénergiques; beta2 adrenoceptor agonist;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D058666;

UMLS CUI

C2936789;

ATC code(s)
- selective beta-2-adrenoreceptor agonists [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Beta-2 adrenergic receptor agonist (disposition) [SNOMED CT concept]
Indexing information
- 5-(2-((6-(2,2-difluoro-2-phenylethoxy)hexyl)amino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one [MeSH Supplementary Concept]
- BI167107 [MeSH Supplementary Concept]
- GW597901 [MeSH Supplementary Concept]
- N-cyclohexyl-N3-(2-(3-fluorophenyl)ethyl)-N-(2-((2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethyl)amino)ethyl)-beta-alaninamide [MeSH Supplementary Concept]
- batefenterol [MeSH Supplementary Concept]
- biphenyl-2-ylcarbamic acid 1-(3-(4-(4-(2-(2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino)ethyl)phenoxy)phenyl)propyl)piperidin-4-yl ester [MeSH Supplementary Concept]
- cimbuterol [MeSH Supplementary Concept]
- mapenterol [MeSH Supplementary Concept]
Manual BTNT mappings - CISMeF
- Long-Acting beta2-adrenergic receptor Agonist [SYNODOS term]
MeSH Descriptor(s) used for indexing
- receptors, adrenergic, beta-2 [MeSH Descriptor]
Record concept(s)
- adrenergic beta-2 receptor agonists [MeSH concept]
See also (suggested by CISMeF)
- receptors, adrenergic, beta-2 [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 3-(4-((6-((-2-hydroxy-2-(4-hydroxy-3-(hydroxymethyl)phenyl)ethyl)amino)hexyl)oxy)butyl)benzenesulfonamide [MeSH Supplementary Concept]
- AZD-3199 [MeSH Supplementary Concept]
- Formoterol Fumarate [MeSH Descriptor]
- LAS190792 [MeSH Supplementary Concept]
- Salmeterol Xinafoate [MeSH Descriptor]
- albuterol [MeSH Descriptor]
- bitolterol [MeSH Supplementary Concept]
- fenoterol [MeSH Descriptor]
- hexoprenaline [MeSH Descriptor]
- isoetharine [MeSH Descriptor]
- metaproterenol [MeSH Descriptor]
- pirbuterol [MeSH Supplementary Concept]
- procaterol [MeSH Descriptor]
- ritodrine [MeSH Descriptor]
- terbutaline [MeSH Descriptor]
- vanidilol [MeSH Supplementary Concept]
- vanidipinedilol [MeSH Supplementary Concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients